lactulose has been researched along with Chronic Disease in 80 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (32.50) | 18.7374 |
| 1990's | 22 (27.50) | 18.2507 |
| 2000's | 14 (17.50) | 29.6817 |
| 2010's | 14 (17.50) | 24.3611 |
| 2020's | 4 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Botoni, FA; da Costa Rocha, MO; da Gama Torres, HO; de Assis Silva Gomes, J; do Carmo Pereira Nunes, M; Pinho, LLN; Rodrigues, AB | 1 |
| Bryce, K; Marelli, L; Ruban, A; Tern, PJW | 1 |
| Almario, CV; Fuller, G; Khalil, C; Nag, A; Oh, SJ; Patel, D; Spalding, W; Spiegel, BMR | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Fields, JZ; Verne, GN; Verne, ML; Zhang, B; Zhou, Q | 1 |
| Cao, Y; Liu, SM | 1 |
| Fukudo, S; Iwai, H; Kasugai, K; Kuboyama, N; Yoshikawa, A | 1 |
| Chen, JY; Hsin, IF; Huang, HC; Tseng, HS; Yang, SF; Yao, YH | 1 |
| Ejerskov Pedersen, C; Jønsson, IM; Krogh, K; Siggaard, C | 1 |
| Guo, M; Li, Y; Wang, J; Yao, D; Yin, J; Zheng, L | 1 |
| Alvarez, A; Bashashati, M; Gomez, Y; Hall, M; McCallum, RW; Sarosiek, I; Sarosiek, J; Shankar, N | 1 |
| Clegg, JP; Guest, JF; Helter, MT | 1 |
| Demetter, P; Devière, J; Goffin, P; Gustot, T; Hols, P; Moreno, C; Nicaise, C; Prozzi, D; Quertinmont, E; Suain, V; Viaene, E | 1 |
| Guest, JF; Taylor, RR | 1 |
| Collins, BS; Lin, HC | 2 |
| Sarin, SK; Sharma, BC; Sharma, P | 1 |
| Bass, NM; Beavers, K; Bortey, E; Forbes, WP; Frederick, T; Hillebrand, D; Huang, S; Leevy, CB; Merchant, K; Mullen, KD; Neff, G; Poordad, F; Sanyal, A; Shaw, A; Sheikh, MY; Sigal, S; Teperman, L | 1 |
| Brooks, DA; Butler, RN; Davidson, GP; Jones, HF | 1 |
| Maydeo, A | 1 |
| D'Incà, R; D'Odorico, A; Di Leo, V; Diaz-Granado, N; Fries, W; Martines, D; Sturniolo, GC; Venturi, C | 1 |
| Ueki, A | 1 |
| Takeuchi, H | 2 |
| Andrieux, C; Bouhnik, Y; Dyard, F; Flourié, B; Guillemot, F; Michel, C; Neut, C; Raskine, L; Riottot, M | 1 |
| Bernauer, E; Finsterer, J | 1 |
| Owira, PM; Winter, TA; Young, GO | 1 |
| de Morais, MB; Fagundes-Neto, U; Lederman, HM; Soares, AC | 1 |
| Kurtovic, J; Riordan, SM; Segal, I | 1 |
| Ho, KS; Ooi, BS; Quah, HM; Seow-Choen, F; Sng, KK | 1 |
| Juttijudata, P; Meensook, C | 1 |
| Crossley, IR; Williams, R | 1 |
| Ferrieri, A; Massimetti, A; Puxeddu, A; Quartini, M | 1 |
| Ehrenpreis, ED; Jorge, JM; Wexner, SD | 1 |
| Bruckschen, E; Möllenbrink, M | 1 |
| Fox, GN | 1 |
| Grigor'ev, AV; Kurik, MV; Shelkovaia, NG; Shor-Chudnovskiĭ, ME; Susak, IaM | 1 |
| Passmore, AP; Scott, ME; Stoker, C; Wilson-Davies, K | 1 |
| Davies, KW; Flanagan, PG; Passmore, AP; Scott, MG; Stoker, C | 1 |
| Kinnunen, O; Koistinen, P; Salokannel, J; Winblad, I | 1 |
| Erwin, L; Fulton, JD; Mack, DJ | 1 |
| Cammà, C; Fabbri, A; Fiorello, F; Marchesini, G; Pagliaro, L; Tinè, F | 1 |
| Heymans, HS; Mulder, CJ; Uil, JJ; van Aalderen, WM; van Elburg, RM | 1 |
| Flourie, B; Sansarricq, M; Sobhani, I | 1 |
| Minocha, A; Rashid, S | 1 |
| Alix, E; Attar, A; Barthet, M; Boutron, MC; Chaussade, S; Ferguson, A; Flourié, B; Guillemot, F; Halphen, M; Lémann, M; Ménard, AM; Moreau, J; Naudin, G; Salmeron, M | 1 |
| Halabi, IM | 1 |
| Fields, JZ; Holmes, EW; Iber, F; Keshavarzian, A; Patel, M; Pethkar, S | 1 |
| Christie, AH; Culbert, P; Guest, JF | 1 |
| Crutchfield, A; Gremse, DA; Hixon, J | 1 |
| Hornick, RB; Levine, MM | 1 |
| Conn, HO; Leevy, CM; Levy, LL; Maddrey, WC; Rodgers, JB; Seeff, L; Vlahcevic, ZR | 1 |
| Bettinger, I; Beyer, P; Carley, J; Greenberger, NJ; Schenker, S; Stamnes, C | 1 |
| Sanders, JF | 1 |
| Benzi-Cipelli, R; Bernardi, R; Magliulo, E; Scevola, D; Trpin, L | 1 |
| Glouberman, S | 1 |
| Pusch, JH; Ullmann, W | 1 |
| Perkin, JM | 1 |
| Maddrey, WC; Weber, FL | 1 |
| Martini, GA | 1 |
| Blanc, P; Daures, JP; Gremy, F; Larrey, D; Michel, H; Peray, P; Pierrugues, R; Rouillon, JM | 1 |
| Atkinson, SN; Chapman, N; Grillage, M; Mahapatra, M; Prescott, P; Rouse, M | 1 |
| Ceccatelli, MP; De Vincentiis, A; Donattini, T; Garavaglia, MC; Giuliani, MG; Lambri, A; Roggero, P; Volpe, C | 1 |
| Aske, DM; Busch, DL; Lederle, FA; Mattox, KM; West, MJ | 1 |
| Ariosto, F; Balducci, G; Capocaccia, L; Merli, M; Riggio, O; Tremiterra, S; Ziparo, V | 1 |
| Bobrowska, E; Boroń, P; Flisiak, R; Kaczmarska, A; Nowak, HF; Szpakowicz, T; Zimnoch, L | 1 |
| Hayashi, K; Ikeda, T; Ito, T; Okada, T; Sakurai, A; Tarao, K; Tsuchiya, T | 1 |
| Hawley, KE; Morgan, MY; Stambuk, D | 1 |
| Fontanella, A; Longo, D; Silano, G; Staiano, A; Vajro, P | 1 |
| Lanthier, PL; Morgan, MY | 1 |
| Neumayr, A | 1 |
| Fischer, JE | 1 |
| Seidlová, V | 1 |
| Devos, J; Guffens, JM; Pirotte, J | 1 |
| Bell, B; Jacobson, S | 1 |
| Balint, JA; Kiley, JE; Rodgers, JB | 1 |
| Frexinos, J; Germain, L; Louis, A; Ribet, A | 2 |
| Nüchter, E | 1 |
| Boonstra, S; Gips, CH; Qué, GS; Van Der Zwan, JC | 1 |
12 review(s) available for lactulose and Chronic Disease
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Lactitol or lactulose in the treatment of chronic constipation: result of a systematic.
Topics: Cathartics; Chronic Disease; Constipation; Gastrointestinal Agents; Humans; Lactulose; Laxatives; Sugar Alcohols; Treatment Outcome | 2010 |
[Chronic liver disease].
Topics: Amino Acids, Branched-Chain; Chronic Disease; Diagnosis, Differential; Diet, Protein-Restricted; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Liver Diseases | 2003 |
[Chronic acquired hepatocerebral degeneration].
Topics: Amino Acids, Branched-Chain; Ammonia; Astrocytes; Basal Ganglia; Brain; Chronic Disease; Dementia; Diagnosis, Differential; Diagnostic Imaging; Hepatolenticular Degeneration; Humans; Lactulose; Manganese | 2004 |
Progress in the treatment of chronic portasystemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin | 1984 |
Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.
Topics: Chronic Disease; Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols; Treatment Outcome | 1993 |
[Chronic acquired(non-Wilsonian) hepatocerebral degeneration(CAHD)].
Topics: Amino Acids, Branched-Chain; Ammonia; Chronic Disease; Hepatolenticular Degeneration; Humans; Lactulose; Liver Diseases; Prognosis | 2000 |
[Long-term treatment of chronic hepatitis and liver cirrhosis].
Topics: Adrenal Cortex Hormones; Anabolic Agents; Chronic Disease; Diagnosis, Differential; Diet Therapy; Dietary Fats; Dietary Proteins; Diuretics; Hepatitis; Humans; Immunosuppressive Agents; Lactulose; Liver Cirrhosis; Liver Diseases; Long-Term Care; Penicillamine; Rest; Vitamin B 12 | 1975 |
Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis.
Topics: Chronic Disease; Clinical Trials as Topic; Evaluation Studies as Topic; Hepatic Encephalopathy; Humans; Lactulose; Meta-Analysis as Topic; Methods; Research Design; Sugar Alcohols | 1992 |
[Advances in the treatment of liver disease].
Topics: Amino Acids; Anti-Bacterial Agents; Chronic Disease; Dihydroxyphenylalanine; Enzyme Induction; Exchange Transfusion, Whole Blood; gamma-Globulins; Hepatic Encephalopathy; Hepatitis; Hepatitis A; Humans; Immunosuppressive Agents; Lactulose; Liver Diseases; Peritoneal Dialysis | 1973 |
Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment.
Topics: Acute Disease; Amino Acids; Ammonia; Brain; Chronic Disease; Colon; Dietary Proteins; Fatty Acids; Glutamine; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Neomycin; Neurotransmitter Agents; Portacaval Shunt, Surgical; Postoperative Complications; Sterilization; Urease | 1974 |
Recognition and management of acute and chronic hepatic encephalopathy.
Topics: Acute Disease; Amines; Ammonia; Animals; Brain Edema; Central Nervous System; Chronic Disease; Diet Therapy; Dihydroxyphenylalanine; Exchange Transfusion, Whole Blood; Fatty Acids, Volatile; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Renal Dialysis | 1973 |
37 trial(s) available for lactulose and Chronic Disease
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Lactulose for the treatment of Chinese children with chronic constipation: A randomized controlled trial.
Topics: Child; Child, Preschool; Chronic Disease; Constipation; Defecation; Feces; Female; Gastrointestinal Agents; Humans; Lactulose; Male; Treatment Outcome | 2018 |
Efficacy and safety of a crystalline lactulose preparation (SK-1202) in Japanese patients with chronic constipation: a randomized, double-blind, placebo-controlled, dose-finding study.
Topics: Adult; Chronic Disease; Constipation; Crystallization; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Japan; Lactulose; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 2019 |
Perioperative Alanyl-Glutamine-Supplemented Parenteral Nutrition in Chronic Radiation Enteritis Patients With Surgical Intestinal Obstruction: A Prospective, Randomized, Controlled Study.
Topics: Adipose Tissue; Adult; Aged; Alanine Transaminase; Body Mass Index; Chronic Disease; Dipeptides; Enteritis; Female; Glutamine; Humans; Intestinal Mucosa; Intestinal Obstruction; Intestines; Lactulose; Male; Mannitol; Middle Aged; Nutritional Status; Parenteral Nutrition; Perioperative Care; Postoperative Period; Prospective Studies; Radiation Injuries; Single-Blind Method; Treatment Outcome; Young Adult | 2016 |
Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Chronic Disease; Drug Resistance; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hypertension, Portal; Hyponatremia; Lactulose; Leukocyte Count; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Young Adult | 2010 |
Rifaximin treatment in hepatic encephalopathy.
Topics: Aged; Anti-Infective Agents; Chronic Disease; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Lactulose; Liver Cirrhosis; Male; Middle Aged; Proportional Hazards Models; Rifamycins; Rifaximin; Secondary Prevention | 2010 |
Double-blind, placebo-controlled antibiotic treatment study of small intestinal bacterial overgrowth in children with chronic abdominal pain.
Topics: Abdominal Pain; Adolescent; Anti-Bacterial Agents; Breath Tests; Child; Chronic Disease; Double-Blind Method; Dyspepsia; Enteritis; Female; Fermentation; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Lactulose; Male; Migraine Disorders; Rifamycins; Rifaximin; Severity of Illness Index; Surveys and Questionnaires | 2011 |
Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation.
Topics: Bile Acids and Salts; Chronic Disease; Colon; Constipation; Excipients; Fatty Acids; Feces; Female; Gastrointestinal Agents; Humans; Hydrogen-Ion Concentration; Lactulose; Male; Middle Aged; Polyethylene Glycols; Prospective Studies; Treatment Outcome | 2004 |
Prospective randomized crossover trial comparing fibre with lactulose in the treatment of idiopathic chronic constipation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Citric Acid; Constipation; Cross-Over Studies; Drug Combinations; Female; Gastrointestinal Agents; Humans; Lactulose; Male; Middle Aged; Patient Satisfaction; Plant Extracts; Prospective Studies; Sodium Bicarbonate; Treatment Outcome | 2006 |
Progress in the treatment of chronic portasystemic encephalopathy.
Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin | 1984 |
Rifaximin in the treatment of chronic hepatic encephalopathy.
Topics: Adult; Aged; Aged, 80 and over; Ammonia; Analysis of Variance; Anti-Bacterial Agents; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Rifamycins; Rifaximin; Time Factors; Treatment Outcome | 1995 |
The lactulose hydrogen breath test as a measure of orocaecal transit time.
Topics: Adult; Aged; Breath Tests; Chronic Disease; Constipation; Diagnosis, Differential; Female; Gastrointestinal Transit; Humans; Hydrogen; Lactulose; Male; Middle Aged; Reproducibility of Results | 1994 |
[Treatment of chronic constipation with physiologic Escherichia coli bacteria. Results of a clinical study of the effectiveness and tolerance of microbiological therapy with the E. coli Nissle 1917 strain (Mutaflor)].
Topics: Adult; Chronic Disease; Constipation; Double-Blind Method; Escherichia coli; Female; Humans; Intestinal Mucosa; Lactulose; Male; Middle Aged | 1994 |
Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination.
Topics: Aged; Aged, 80 and over; Chronic Disease; Constipation; Cost-Benefit Analysis; Double-Blind Method; Drug Combinations; Drug Costs; Female; Hospitalization; Humans; Lactulose; Long-Term Care; Male; Senna Extract | 1993 |
A comparison of Agiolax and lactulose in elderly patients with chronic constipation.
Topics: Aged; Aged, 80 and over; Cathartics; Chronic Disease; Constipation; Double-Blind Method; Drug Combinations; Female; Gastric Emptying; Gastrointestinal Motility; Humans; Lactulose; Male; Plant Extracts; Plantago; Senna Extract | 1993 |
Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients.
Topics: Aged; Aged, 80 and over; Cathartics; Chronic Disease; Constipation; Drug Combinations; Female; Gastric Emptying; Gastrointestinal Motility; Humans; Lactulose; Male; Plant Extracts; Plantago; Senna Extract | 1993 |
Chronic constipation in elderly patients.
Topics: Aged; Aged, 80 and over; Chronic Disease; Constipation; Drug Combinations; Humans; Lactulose; Senna Extract | 1993 |
Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis.
Topics: Chronic Disease; Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols; Treatment Outcome | 1993 |
[Laxative effect and tolerance of lactulose administrated in one or two intakes in the treatment of chronic idiopathic constipation. Groupe d'Investigateurs O'Ile-de-France (GIIF)].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Constipation; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastrointestinal Agents; Humans; Lactulose; Male; Middle Aged | 1996 |
Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation.
Topics: Adult; Aged; Cathartics; Chronic Disease; Constipation; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Lactulose; Male; Middle Aged; Polyethylene Glycols; Potassium Chloride; Sodium Bicarbonate; Sodium Chloride; Treatment Outcome | 1999 |
Cisapride in management of chronic pediatric constipation.
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Cisapride; Constipation; Double-Blind Method; Fecal Impaction; Female; Gastrointestinal Agents; Gastrointestinal Motility; Humans; Lactulose; Male; Placebos | 1999 |
Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Constipation; Cost-Benefit Analysis; Decision Support Techniques; Drug Administration Schedule; Drug Therapy, Combination; Economics, Pharmaceutical; Electrolytes; Gastrointestinal Agents; Humans; Lactulose; Middle Aged; Polyethylene Glycols; Treatment Outcome; United Kingdom | 2002 |
Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children.
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Constipation; Cross-Over Studies; Female; Humans; Lactulose; Male; Polyethylene Glycols; Treatment Outcome | 2002 |
Lactulose therapy in Shigella carrier state and acute dysentery.
Topics: Acute Disease; Adolescent; Adult; Ampicillin; Carrier State; Chronic Disease; Disaccharides; Dysentery, Bacillary; Feces; Humans; Hydrogen-Ion Concentration; Lactulose; Male; Time Factors | 1975 |
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
Topics: Aged; Ammonia; Blood; Chronic Disease; Clinical Trials as Topic; Disaccharides; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Male; Mental Processes; Middle Aged; Neomycin; Prospective Studies; Sorbitol; Trail Making Test | 1977 |
Effect of vegetable and animal protein diets in chronic hepatic encephalopathy.
Topics: Adult; Amino Acids; Chronic Disease; Clinical Trials as Topic; Dietary Proteins; Female; Hepatic Encephalopathy; Humans; Intelligence Tests; Lactulose; Liver Cirrhosis; Liver Function Tests; Male; Meat; Methionine; Middle Aged; Plant Proteins, Dietary; Proteins | 1977 |
Lactulose syrup assessed in a double-blind study of elderly constipated patients.
Topics: Aged; Chronic Disease; Clinical Trials as Topic; Constipation; Disaccharides; Double-Blind Method; Female; Humans; Lactulose; Male; Middle Aged | 1978 |
Constipation in childhood: a controlled comparison between lactulose and standardized senna.
Topics: Child; Chronic Disease; Constipation; Disaccharides; Humans; Lactulose; Senna Extract | 1977 |
An open, randomised, parallel group study of lactulose versus ispaghula in the treatment of chronic constipation in adults.
Topics: Bicarbonates; Chronic Disease; Citrates; Citric Acid; Constipation; Drug Combinations; Humans; Lactulose; Middle Aged; Patient Acceptance of Health Care; Plant Extracts; Prospective Studies; Sodium Bicarbonate | 1991 |
[Crystalline lactulose and oral preparations of micro-organisms for the treatment of chronic aspecific diarrhea in children. A controlled clinical study].
Topics: Child, Preschool; Chronic Disease; Diarrhea; Diarrhea, Infantile; Disaccharides; Feces; Female; Humans; Hydrogen-Ion Concentration; Infant; Intestines; Lactobacillus; Lactococcus lactis; Lactulose; Male; Randomized Controlled Trials as Topic | 1990 |
Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose.
Topics: Aged; Aged, 80 and over; Chronic Disease; Constipation; Cost-Benefit Analysis; Double-Blind Method; Feces; Flatulence; Humans; Lactulose; Male; Medical Records; Nausea; Random Allocation; Sorbitol | 1990 |
Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
Topics: Adult; Aged; Chronic Disease; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Surgical; Sugar Alcohols | 1990 |
Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Disaccharides; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Random Allocation; Sugar Alcohols | 1987 |
Comparison of results of long-term treatment of chronic hepatic encephalopathy with lactulose and sorbitol.
Topics: Aged; Chronic Disease; Clinical Trials as Topic; Disaccharides; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Sorbitol | 1973 |
[Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
Topics: Adult; Aged; Ammonia; Brain Diseases; Chronic Disease; Clinical Trials as Topic; Disaccharides; Electroencephalography; Female; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neurologic Manifestations; Placebos; Portacaval Shunt, Surgical | 1973 |
[Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
Topics: Adult; Aged; Ammonia; Brain Diseases; Chronic Disease; Clinical Trials as Topic; Disaccharides; Electroencephalography; Female; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neurologic Manifestations; Placebos; Portacaval Shunt, Surgical | 1973 |
[New ways in the treatment of chronic obstipation].
Topics: Adolescent; Adult; Aged; Cathartics; Chronic Disease; Clinical Trials as Topic; Constipation; Diarrhea; Drug Evaluation; Female; Humans; Lactulose; Male; Middle Aged; Nausea | 1974 |
34 other study(ies) available for lactulose and Chronic Disease
| Article | Year |
|---|---|
Intestinal permeability evaluation in patients with chronic Chagas heart failure.
Topics: Adult; Chronic Disease; Female; Heart Failure; Humans; Lactulose; Male; Mannitol; Middle Aged; Permeability; Stroke Volume; Ventricular Function, Left | 2023 |
Hepatic encephalopathy: a rare cause of focal seizures in chronic liver disease.
Topics: Aftercare; Anticonvulsants; Chronic Disease; Diagnosis, Differential; Electroencephalography; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Diseases; Magnetic Resonance Imaging; Middle Aged; Rifaximin; Seizures; Treatment Outcome | 2020 |
Chronic Constipation in the United States: Results From a Population-Based Survey Assessing Healthcare Seeking and Use of Pharmacotherapy.
Topics: Adult; Age Factors; Bisacodyl; Chronic Disease; Colonoscopy; Constipation; Dietary Fiber; Dioctyl Sulfosuccinic Acid; Emergency Service, Hospital; Employment; Ethnicity; Female; Gastroenterologists; Gastrointestinal Agents; Guanylyl Cyclase C Agonists; Humans; Insurance, Health; Internal-External Control; Lactulose; Laxatives; Male; Marital Status; Middle Aged; Nonprescription Drugs; Patient Acceptance of Health Care; Peptides; Physicians, Primary Care; Polyethylene Glycols; Sennosides; Severity of Illness Index; Sex Factors; Surface-Active Agents; Surveys and Questionnaires; United States | 2020 |
Intestinal Hyperpermeability in Gulf War Veterans With Chronic Gastrointestinal Symptoms.
Topics: Abdominal Pain; Adult; Chronic Disease; Diarrhea; Female; Gastrointestinal Diseases; Gulf War; Humans; Intestines; Lactulose; Male; Mannitol; Middle Aged; Permeability; United States; Veterans | 2019 |
A patient with hemodialysis-related hyperammonemic encephalopathy: a delayed presentation of congenital arterioportal fistulas.
Topics: Adult; Arteriovenous Fistula; Chronic Disease; Embolization, Therapeutic; Female; Gastrointestinal Agents; Hepatic Artery; Hepatic Encephalopathy; Humans; Hyperammonemia; Incidental Findings; Lactulose; Nephritis, Interstitial; Portal Vein; Renal Dialysis; Treatment Outcome | 2013 |
[Treatment of chronic constipation in children].
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Constipation; Defecation; Humans; Lactulose; Laxatives; Osmosis; Polyethylene Glycols; Radiography; Review Literature as Topic | 2013 |
Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation.
Topics: Adult; Blind Loop Syndrome; Breath Tests; Chronic Disease; Constipation; Female; Gastrointestinal Agents; Gastrointestinal Transit; Humans; Intestine, Small; Lactulose; Lubiprostone; Middle Aged; Treatment Outcome; Young Adult | 2016 |
Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK.
Topics: Aged; Aged, 80 and over; Chronic Disease; Constipation; Cost-Benefit Analysis; Female; Health Status; Humans; Lactulose; Laxatives; Male; Middle Aged; Polyethylene Glycols; Quality-Adjusted Life Years; Treatment Outcome; United Kingdom | 2008 |
Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents.
Topics: Acute Disease; Alanine; Ammonia; Animals; Carbon Tetrachloride; Chronic Disease; Disease Models, Animal; Hyperammonemia; Lactobacillus plantarum; Lactulose; Liver Failure; Male; Mice; Mice, Inbred C57BL; Probiotics; Rats; Rats, Inbred Lew; Thioacetamide | 2008 |
The cost-effectiveness of macrogol 3350 compared to lactulose in the treatment of adults suffering from chronic constipation in the UK.
Topics: Adult; Aged; Chronic Disease; Constipation; Cost-Benefit Analysis; Female; Humans; Lactulose; Laxatives; Male; Middle Aged; Models, Economic; National Health Programs; Polyethylene Glycols; Quality of Life; Treatment Outcome; United Kingdom | 2010 |
Chronic abdominal pain in children is associated with high prevalence of abnormal microbial fermentation.
Topics: Abdominal Pain; Adolescent; Bacteria; Breath Tests; Child; Chronic Disease; Dyspepsia; Female; Fermentation; Humans; Intestine, Small; Irritable Bowel Syndrome; Lactulose; Male | 2010 |
Is small-bowel bacterial overgrowth an underdiagnosed disorder in children with gastrointestinal symptoms?
Topics: Abdominal Pain; Adolescent; Blind Loop Syndrome; Breath Tests; Child; Child, Preschool; Chronic Disease; Diagnostic Errors; Humans; Hydrogen; Infant; Intestine, Small; Irritable Bowel Syndrome; Lactulose; Malabsorption Syndromes; Retrospective Studies | 2011 |
Lactulose/mannitol test has high efficacy for excluding organic causes of chronic diarrhea.
Topics: C-Reactive Protein; Chronic Disease; Cohort Studies; Diarrhea; Feces; Female; Gastroenterology; Gastrointestinal Motility; Humans; Intestinal Absorption; Lactulose; Logistic Models; Male; Mannitol; Multivariate Analysis; Permeability; Probability; Prospective Studies; Sensitivity and Specificity; Severity of Illness Index | 2003 |
Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy.
Topics: Anti-Bacterial Agents; Antiparkinson Agents; Benzothiazoles; Brain; Chronic Disease; Dipeptides; Evoked Potentials, Visual; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Paromomycin; Pramipexole; Recovery of Function; Thiazoles; Treatment Outcome; Vision Disorders | 2005 |
Comparison of inulin and lactulose as reference standards in the breath hydrogen test assessment of carbohydrate malabsorption in patients with chronic pancreatic exocrine insufficiency.
Topics: Adult; Breath Tests; Chronic Disease; Dietary Carbohydrates; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Humans; Hydrogen; Inulin; Lactulose; Middle Aged; Reference Standards | 2005 |
Breath hydrogen test after a bean meal demonstrates delayed oro-cecal transit time in children with chronic constipation.
Topics: Adolescent; Breath Tests; Case-Control Studies; Child; Child, Preschool; Chronic Disease; Colon; Constipation; Fabaceae; Female; Gastrointestinal Transit; Humans; Hydrogen; Lactulose; Male; Time Factors | 2005 |
Culture-proven small intestinal bacterial overgrowth as a cause of irritable bowel syndrome: response to lactulose but not broadspectrum antibiotics.
Topics: Abdominal Pain; Anti-Bacterial Agents; Bacterial Infections; Chronic Disease; Colonoscopy; Drug Resistance, Bacterial; Drug Therapy, Combination; Follow-Up Studies; Humans; Intestine, Small; Irritable Bowel Syndrome; Lactulose; Male; Middle Aged; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome | 2005 |
Lactulose in the treatment of chronic hepatic encephalopathy: report of three cases.
Topics: Adult; Chronic Disease; Fatal Outcome; Follow-Up Studies; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Treatment Outcome | 1981 |
Treatment and cost concerns for chronic constipation.
Topics: Cathartics; Child; Chronic Disease; Constipation; Cost Control; Drug Costs; Humans; Lactulose; Sorbitol | 1994 |
[The possibilities for correcting the dysbacteriosis occurring in the prolonged external diversion of bile].
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bile; Biological Products; Cholecystitis; Cholelithiasis; Cholestasis; Chronic Disease; Drainage; Drug Therapy, Combination; Humans; Intestinal Diseases; Lactulose; Middle Aged; Postoperative Complications | 1993 |
Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis.
Topics: Adolescent; Adult; Capillary Permeability; Carbohydrates; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Exocrine Pancreatic Insufficiency; Humans; Infant; Intestinal Mucosa; Lactulose; Mannitol; Nutritional Physiological Phenomena; Osmolar Concentration; Pancreatitis | 1996 |
Reliability and reproducibility of breath hydrogen and methane in male diabetic subjects.
Topics: Adult; Analysis of Variance; Breath Tests; Chi-Square Distribution; Chronic Disease; Diabetes Mellitus, Type 1; Humans; Hydrogen; Lactulose; Male; Methane; Middle Aged; Reproducibility of Results; Time Factors | 1997 |
Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage.
Topics: Aged; Alcoholism; Chronic Disease; Digestive System; Humans; Intestinal Absorption; Lactulose; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Mannitol; Middle Aged; Permeability; Sucrose | 1999 |
Control of endotoxinemia in liver disease by lactulose and paromomycin.
Topics: Chronic Disease; Disaccharides; Endotoxins; Hepatitis; Hepatitis B; Humans; Lactulose; Limulus Test; Liver Cirrhosis; Liver Diseases; Paromomycin | 1979 |
Hepatic encephalopathy.
Topics: Chronic Disease; Hepatic Encephalopathy; Humans; Lactulose; Neomycin | 1977 |
Chronic hepatic encephalopathy.
Topics: Amino Acids, Essential; Ammonia; Analgesics; Anesthesia; Anti-Bacterial Agents; Biogenic Amines; Chronic Disease; Constipation; Dietary Proteins; Dihydroxyphenylalanine; Diuretics; Fatty Acids; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Hypnotics and Sedatives; Infections; Lactulose; Methionine; Portacaval Shunt, Surgical; Tranquilizing Agents; Uremia | 1975 |
[Psychiatric-neurological disorders in chronic liver diseases].
Topics: Acute Disease; Ammonia; Biotransformation; Brain Damage, Chronic; Brain Diseases; Chronic Disease; Dietary Proteins; Diuretics; Glutamine; Humans; Lactulose; Liver Diseases; Mental Disorders; Portacaval Shunt, Surgical; Postoperative Complications; Prognosis | 1975 |
[Effect of differentiated diet therapy on the clinical results and biochemical indicators in chronic hepatic encephalopathy].
Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Brain; Brain Chemistry; Chronic Disease; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Liver | 1990 |
[Therapeutic effect of vancomycin hydrochloride, a nonabsorbable antibiotic, on intractable (lactulose resistant) chronic hepatic encephalopathy in cirrhotic patients].
Topics: Aged; Chronic Disease; Drug Resistance; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Vancomycin | 1986 |
Orocoecal transit time in healthy and constipated children.
Topics: Breath Tests; Child; Child, Preschool; Chronic Disease; Constipation; Female; Food; Gastrointestinal Transit; Humans; Hydrogen; Lactulose; Male | 1988 |
Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose.
Topics: Adult; Ammonia; Cerebrovascular Circulation; Chronic Disease; Disaccharides; Electroencephalography; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Patient Acceptance of Health Care; Psychological Tests; Sugar Alcohols; Time Factors; Veins | 1985 |
[Lactulose in the treatment of chronic portosystemic encephalopathies].
Topics: Adult; Aged; Chronic Disease; Disaccharides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Diseases; Male; Mental Disorders; Middle Aged; Nervous System Diseases | 1974 |
Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.
Topics: Ammonia; Blood Urea Nitrogen; Brain Diseases; Chlorides; Chronic Disease; Disaccharides; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Liver Cirrhosis; Liver Function Tests; Neomycin; Potassium; Sodium | 1974 |
Milk protein in the treatment of chronic portasystemic encephalopathy. A long-term study of therapeutic measures in a patient with chronic porta-systemic encephalopathy.
Topics: Aged; Ammonia; Animals; Chronic Disease; Diet Therapy; Dogs; Electroencephalography; Hepatic Encephalopathy; Humans; Lactose; Lactulose; Male; Milk Proteins; Neomycin; Portal System | 1974 |